Dror Bacher - DarioHealth Corp Chief Officer

DRIO Stock  USD 1.53  0.01  0.66%   

Executive

Mr. Dror Bacher serves as Chief Operating Officer of the company. Mr. Bacher previously served as our Vice President of Research and development as well as Vice President of Operations since 2013 where he worked on product development as well as building a scalable supply chain. Mr. Bacher has over 18 years of experience in various technological companies and his expertise includes product management, product development and business operations in multi disciplinary environments. Between 2008 and 2013, Mr. Bacher Served in several leadership roles at Amdocs Limited, including working as a part of the Chief Technology Office, managing enterprise development. programs for a variety of software products associated with service delivery, as well as serving as head of process Prior to Amdocs, Mr. Bacher served in a senior role at Tower Semiconductor, the global specialty foundry leader for IC manufacturing, where he was responsible for business operations and commercialization expansion since 2017.
Age 49
Tenure 7 years
Professional MarksMBA
Address 18 West 18th Street, New York, NY, United States, 10011
Phone833 914 3796
Webhttps://www.dariohealth.com

Latest Insider Transactions

2021-11-04Disposed of 200 shares @ 19.08View
2021-11-02Disposed of 4363 shares @ 19.07View
2021-07-06Disposed of 2479 shares @ 20.32View
2021-07-02Disposed of 11021 shares @ 20.63View
Bacher holds a B.Sc. in computer science and an MBA degree from Haifa University.

DarioHealth Corp Management Efficiency

The company has return on total asset (ROA) of (0.2737) % which means that it has lost $0.2737 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7359) %, meaning that it created substantial loss on money invested by shareholders. DarioHealth Corp's management efficiency ratios could be used to measure how well DarioHealth Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of March 2024, Return On Capital Employed is likely to grow to 4.72, while Return On Assets are likely to drop (0.49). At this time, DarioHealth Corp's Fixed Asset Turnover is very stable compared to the past year. As of the 29th of March 2024, Asset Turnover is likely to grow to 0.39, while Non Currrent Assets Other are likely to drop about 86 K.
The company currently holds 29.54 M in liabilities with Debt to Equity (D/E) ratio of 0.23, which may suggest the company is not taking enough advantage from borrowing. DarioHealth Corp has a current ratio of 6.22, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist DarioHealth Corp until it has trouble settling it off, either with new capital or with free cash flow. So, DarioHealth Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DarioHealth Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DarioHealth to invest in growth at high rates of return. When we think about DarioHealth Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

MA BSNMedpace Holdings
61
Mark AguillardDermTech
N/A
Todd MeyersMedpace Holdings
N/A
Jerry LanchburyMyriad Genetics
58
Scott PowellVolitionrx
50
Stephen EwaldMedpace Holdings
55
Reinilde MDMedpace Holdings
63
Rodney LLBVolitionrx
53
Jacob MBAVolitionrx
68
JD EsqDermTech
55
Gael MBAVolitionrx
42
Louise DayasVolitionrx
N/A
Frank KriegSchneiderMainz Biomed BV
N/A
Jennifer HigginsGuardant Health
N/A
Richard LanmanGuardant Health
63
Daniel VisageDermTech
N/A
Michael WileyGuardant Health
42
John MBAMedpace Holdings
N/A
Loren MDDermTech
N/A
William BautaBioAffinity Technologies Warran
N/A
Terilyn MonroeGuardant Health
57
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Dario Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 200 people. DarioHealth Corp (DRIO) is traded on NASDAQ Exchange in USA. It is located in 18 West 18th Street, New York, NY, United States, 10011 and employs 241 people. DarioHealth Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

DarioHealth Corp Leadership Team

Elected by the shareholders, the DarioHealth Corp's board of directors comprises two types of representatives: DarioHealth Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DarioHealth. The board's role is to monitor DarioHealth Corp's management team and ensure that shareholders' interests are well served. DarioHealth Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DarioHealth Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Glen Moller, Director
Josh Fischer, Senior Compliance
Dov Oppenheim, CoFounder Chief
Rami Yehudiha, Director
Hila Karah, Director
Richard Anderson, President
Claudia Levi, Content Manager
Jean Muyl, Head America
Zvi David, Treasurer CFO
Yalon Farhi, Director
Erez Raphael, Chairman, CEO and Pres
Ori Zanco, Director
Mary Mooney, Vice Marketing
Limor Drezner, Chief Officer
Dennis McGrath, Director
Olivier Jarry, President and Chief Commercial Officer
Malcolm Hoenlein, Independent Director
Richard Stone, Independent Director
Tomer BenKiki, Chief Officer
Brian Harrigan, Senior Sales
Yossi Bahagon, Director
Yoav Shaked, Chairman of the Board
Dror Bacher, Chief Officer
Zvi BenDavid, CFO, Treasurer, Secretary
Allen Kamer, Director
Omar MD, Chief Officer

DarioHealth Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DarioHealth Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DarioHealth Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DarioHealth Corp's short interest history, or implied volatility extrapolated from DarioHealth Corp options trading.

Pair Trading with DarioHealth Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.

Moving together with DarioHealth Stock

  0.84MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr

Moving against DarioHealth Stock

  0.72TNDM Tandem Diabetes Care Financial Report 1st of May 2024 PairCorr
  0.72A Agilent Technologies Earnings Call TodayPairCorr
  0.67SNDA Sonida Senior Living Report 4th of April 2024 PairCorr
  0.54RDNT RadNet Inc Financial Report 14th of May 2024 PairCorr
  0.5COO Cooper Companies Financial Report 6th of June 2024 PairCorr
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DarioHealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DarioHealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dariohealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dariohealth Corp Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for DarioHealth Stock analysis

When running DarioHealth Corp's price analysis, check to measure DarioHealth Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DarioHealth Corp is operating at the current time. Most of DarioHealth Corp's value examination focuses on studying past and present price action to predict the probability of DarioHealth Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DarioHealth Corp's price. Additionally, you may evaluate how the addition of DarioHealth Corp to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
CEOs Directory
Screen CEOs from public companies around the world
Is DarioHealth Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.04)
Revenue Per Share
0.852
Quarterly Revenue Growth
(0.47)
Return On Assets
(0.27)
Return On Equity
(0.74)
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.